Joel Greenblatt’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
46,822
-30,147
-39% -$698K ﹤0.01% 1310
2026
Q1
$1.58M Buy
76,969
+39,974
+108% +$901K ﹤0.01% 1175
2025
Q4
$877K Buy
36,995
+6,773
+22% +$165K ﹤0.01% 1298
2025
Q3
$753K Sell
30,222
-8,423
-22% -$181K ﹤0.01% 1284
2025
Q2
$889K Buy
+38,645
New +$895K 0.01% 1173
2024
Q3
Sell
-20,037
Closed -$348K 1505
2024
Q2
$348K Sell
20,037
-44,800
-69% -$794K ﹤0.01% 1191
2024
Q1
$1.27M Sell
64,837
-5,155
-7% -$109K 0.02% 784
2023
Q4
$1.61M Buy
69,992
+10,435
+18% +$234K 0.03% 677
2023
Q3
$1.37M Buy
59,557
+29,465
+98% +$749K 0.03% 668
2023
Q2
$786K Buy
30,092
+21,677
+258% +$573K 0.02% 841
2023
Q1
$232K Buy
+8,415
New +$222K 0.01% 1219

Other funds holding PRVA

Joel Greenblatt's PRVA Position: Q2 2026 in Review

Joel Greenblatt reduced its Privia Health (PRVA) stake by 39% in Q2 2026, selling an estimated $698K and leaving 46,822 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Joel Greenblatt first reported a position in PRVA in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.61M in Q4 2023. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Joel Greenblatt held 46,822 shares of Privia Health worth $1.2M as of Q2 2026.
  • Joel Greenblatt sold 30,147 Privia Health shares in Q2 2026, an estimated $698K.
  • Privia Health made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1310 holding.
  • Joel Greenblatt first reported a position in Privia Health in Q1 2023 and has held it in 11 quarters since.
  • Joel Greenblatt's Privia Health position peaked at $1.61M in Q4 2023.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.